depression on tirzepatide Weight-Loss Therapy Not Linked to or Suicidal Risk: Study Finds Psychiatric Safety of Tirzepatide: 3
Description
Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH
Busch (as part of Heart in Diabetes (HiD)), posted on Oct 8, 2024.

From Botox to IV Therapy, book your slot and embark on a transformative journey in Phoenix, AZ.

Dr Reddy's Laboratories is poised to launch its generic semaglutide injection, potentially named Obeda, in India by March

Everything we know about GLP-1s so far

Discover if green tea increases GLP-1 levels naturally
